Dr. Marcelo Kremenchutzky, Director of the MS Clinic in London, Ontario, interviews researchers and clinicians at MSBoston 2014, the joint meeting of the Americas and European Committee for Treatment and Research in MS (ACTRIMS/ECTRIMS).
Latest News
NeuroSound Radio at ACTRIMS/ECTRIMS 2014 – Part 1
November 5, 2014Dr. Marcelo Kremenchutzky, Director of the MS Clinic in London, Ontario, interviews researchers and clinicians at MSBoston 2014, the joint meeting of the Americas and European Committee for Treatment and Research in MS (ACTRIMS/ECTRIMS). Read More
Toward a new standard in MS disease control
October 22, 2014REVIEWER: Dr. Mark S. Freedman, Director, Multiple Sclerosis Research Unit, The Ottawa Hospital, Ottawa, Canada
Redefining therapeutic efficacy
Conclusions
New data on novel and emerging therapies were the centrepiece of the 2014 joint meeting of the Americas and European Committee for Research and Treatment of Multiple Sclerosis (ACTRIMS/ECTRIMS), with results suggesting that clinical standards are being redefined for optimal disease control in relapsing-remitting multiple sclerosis (RRMS). Read More
Poor adherence to migraine prophylaxis
October 8, 2014Short-term adherence to migraine prophylaxis is poor, with about one-half of patients stopping their medication within a year, according to the results of a systematic review (Hepp et al. J Manag Care Pharm 2014;20:22-33). Read More